Lynch Henry T, Lynch Jane F
Department of Preventive Medicine and Public Health, Creighton University School of Medicine, 2500 California Plaza, Omaha, Nebraska 68131, USA.
Biochimie. 2002 Jan;84(1):3-17. doi: 10.1016/s0300-9084(01)01363-3.
The translation of knowledge about hereditary breast cancer and its improved control, as well as prevention through prophylactic surgery, has been significantly accelerated through the veritable explosive discoveries in molecular genetics inclusive of BRCA1 and BRCA2 germline mutations. Needed however, among the physician community, medical geneticists, and genetic counselors, is a raised level of knowledge about hereditary breast cancer syndromes. Particular attention needs to be given to their extant genotypic and phenotypic heterogeneity, their natural history, and foremost, the requirement of a sufficiently detailed family history, with knowledge as to how to interpret its significance so that hereditary cancer syndrome can be diagnosed, should it, in fact, exist in the particular family. Collectively, surveillance and management programs can then be developed for the patient and his or her high-risk relatives. We believe very firmly that this knowledge needs to be extended to the individual patient(s), first- and second-degree relatives so that they can benefit from this knowledge.
分子遗传学领域包括 BRCA1 和 BRCA2 种系突变在内的一系列重大发现,显著加速了遗传性乳腺癌相关知识的传播以及对其控制的改善,包括通过预防性手术进行预防。然而,在医生群体、医学遗传学家和遗传咨询师中,需要提高对遗传性乳腺癌综合征的认识水平。尤其需要关注其现有的基因型和表型异质性、自然病史,最重要的是,需要详细的家族病史,并了解如何解读其意义,以便在特定家族中实际存在遗传性癌症综合征时能够进行诊断。在此基础上,就可以为患者及其高危亲属制定监测和管理方案。我们坚信,这些知识需要推广到个体患者及其一级和二级亲属,以便他们能够从中受益。